Find the investors funding Health Series A rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Ai3Bio Launches With $48M Series A to Reset Immune System - citybiz.co
Ai3Bio has launched with a $48 million Series A funding round. The company aims to reset the immune system, suggesting a focus on novel therapeutic approaches for immune-related diseases.
Ai3Bio Launches With $48M Series A to Reset Immune System citybiz.co
| Oct 08, 2026 | Phantom GI | $5.0M | Seed | Israel |
| Oct 08, 2026 | Yazen | $60.4M | Late-stage | Sweden |
| Oct 07, 2026 | A Nobel Prize Winner’s Startup | $350.0M | — | — |
| Oct 07, 2026 | Vitalize | $31.0M | — | — |
You just read who funded Ai3Bio. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.